| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.991 | |
| extracellular structure organization | GO:0043062 | 148 | 0.988 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.987 | |
| response to amino acid | GO:0043200 | 37 | 0.978 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.813 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.788 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.715 | |
| protein trimerization | GO:0070206 | 13 | 0.713 | Human |
| regulation of cell adhesion | GO:0030155 | 154 | 0.707 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.707 | |
| fibril organization | GO:0097435 | 2 | 0.701 | |
| ossification | GO:0001503 | 216 | 0.683 | Human |
| connective tissue development | GO:0061448 | 179 | 0.674 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.667 | |
| response to growth factor | GO:0070848 | 198 | 0.646 | |
| skeletal system development | GO:0001501 | 356 | 0.643 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.594 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.582 | |
| palate development | GO:0060021 | 76 | 0.562 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.555 | Human |
| aorta smooth muscle tissue morphogenesis | GO:0060414 | 2 | 0.516 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.500 | |
| limb bud formation | GO:0060174 | 10 | 0.495 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.490 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.480 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.475 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.462 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.455 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.445 | |
| cell adhesion | GO:0007155 | 329 | 0.421 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.400 | |
| bone development | GO:0060348 | 120 | 0.378 | |
| cartilage condensation | GO:0001502 | 18 | 0.376 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.353 | |
| extracellular fibril organization | GO:0043206 | 2 | 0.330 | |
| lung development | GO:0030324 | 164 | 0.319 | |
| respiratory tube development | GO:0030323 | 167 | 0.303 | |
| protein oligomerization | GO:0051259 | 67 | 0.290 | Human |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.273 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.270 | |
| response to acid chemical | GO:0001101 | 111 | 0.259 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.251 | Human |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.239 | |
| sensory perception of sound | GO:0007605 | 97 | 0.232 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.228 | |
| regulation of cell motility | GO:2000145 | 236 | 0.226 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.225 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.224 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.223 | |
| head morphogenesis | GO:0060323 | 34 | 0.220 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.216 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.215 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.212 | |
| limb morphogenesis | GO:0035108 | 149 | 0.211 | |
| muscle tissue development | GO:0060537 | 308 | 0.206 | |
| wound healing | GO:0042060 | 157 | 0.204 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.202 | |
| bone trabecula formation | GO:0060346 | 9 | 0.202 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.200 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.196 | |
| forebrain development | GO:0030900 | 302 | 0.194 | |
| replacement ossification | GO:0036075 | 26 | 0.191 | |
| response to superoxide | GO:0000303 | 16 | 0.185 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.170 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.169 | |
| cartilage development | GO:0051216 | 140 | 0.166 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.165 | |
| negative regulation of tooth mineralization | GO:0070171 | 1 | 0.157 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.155 | |
| bone morphogenesis | GO:0060349 | 78 | 0.153 | |
| notochord development | GO:0030903 | 20 | 0.153 | |
| basement membrane organization | GO:0071711 | 8 | 0.150 | |
| aorta development | GO:0035904 | 23 | 0.149 | |
| sensory perception | GO:0007600 | 245 | 0.148 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.147 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.145 | |
| trabecula formation | GO:0060343 | 24 | 0.144 | |
| protein hydroxylation | GO:0018126 | 4 | 0.143 | |
| collagen fibril organization | GO:0030199 | 32 | 0.136 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.134 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.132 | |
| face development | GO:0060324 | 38 | 0.131 | |
| negative regulation of neuron migration | GO:2001223 | 6 | 0.130 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.129 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.129 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.127 | |
| tissue homeostasis | GO:0001894 | 115 | 0.126 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.124 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.120 | |
| heart morphogenesis | GO:0003007 | 178 | 0.119 | |
| cell aggregation | GO:0098743 | 18 | 0.118 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.117 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.116 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.114 | |
| direct ossification | GO:0036072 | 5 | 0.111 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.110 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.110 | |
| cerebral cortex development | GO:0021987 | 86 | 0.108 | |
| regulation of cell migration | GO:0030334 | 219 | 0.105 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.102 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.102 | |
| neuron migration | GO:0001764 | 122 | 0.101 | |
| angiogenesis | GO:0001525 | 201 | 0.099 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.096 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.093 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.092 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.090 | |
| limb development | GO:0060173 | 166 | 0.090 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.089 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.088 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.088 | |
| response to catecholamine | GO:0071869 | 4 | 0.084 | |
| respiratory system development | GO:0060541 | 190 | 0.084 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.083 | |
| nephron development | GO:0072006 | 109 | 0.081 | |
| digestive system development | GO:0055123 | 200 | 0.081 | Human |
| negative regulation of ossification | GO:0030279 | 49 | 0.081 | |
| artery development | GO:0060840 | 53 | 0.081 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.079 | |
| cellular response to bmp stimulus | GO:0071773 | 14 | 0.078 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.076 | |
| response to inorganic substance | GO:0010035 | 96 | 0.075 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.075 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.073 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.072 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.072 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.070 | |
| appendage development | GO:0048736 | 166 | 0.067 | |
| body morphogenesis | GO:0010171 | 45 | 0.067 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.066 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.066 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.064 | |
| regulation of sphingolipid biosynthetic process | GO:0090153 | 1 | 0.062 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.061 | |
| digestive tract development | GO:0048565 | 190 | 0.060 | Human |
| face morphogenesis | GO:0060325 | 29 | 0.060 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.058 | |
| renal system development | GO:0072001 | 225 | 0.058 | |
| collagen metabolic process | GO:0032963 | 17 | 0.057 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.057 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.056 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.056 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.056 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.056 | |
| response to bmp | GO:0071772 | 14 | 0.055 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.054 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.053 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.052 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.051 | |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 1 | 0.049 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.048 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.048 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.047 | |
| skin development | GO:0043588 | 220 | 0.046 | |
| ear development | GO:0043583 | 200 | 0.045 | |
| urogenital system development | GO:0001655 | 261 | 0.044 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.044 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.044 | |
| tendon development | GO:0035989 | 6 | 0.043 | |
| otic vesicle development | GO:0071599 | 14 | 0.043 | |
| tissue migration | GO:0090130 | 68 | 0.043 | |
| gland development | GO:0048732 | 330 | 0.043 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.042 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.042 | |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.042 | |
| defense response to bacterium | GO:0042742 | 119 | 0.042 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.041 | |
| chondrocyte development | GO:0002063 | 24 | 0.041 | |
| spermatogenesis | GO:0007283 | 284 | 0.040 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.040 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.039 | |
| insulin metabolic process | GO:1901142 | 3 | 0.039 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.039 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.039 | |
| plasma membrane organization | GO:0007009 | 90 | 0.038 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.038 | |
| response to oxidative stress | GO:0006979 | 123 | 0.038 | |
| pallium development | GO:0021543 | 120 | 0.037 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.036 | |
| regulation of endodermal cell differentiation | GO:1903224 | 2 | 0.036 | |
| bone resorption | GO:0045453 | 38 | 0.036 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.035 | |
| response to peptide hormone | GO:0043434 | 127 | 0.035 | |
| response to peptide | GO:1901652 | 136 | 0.035 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.035 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.034 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.033 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.033 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.032 | |
| peptide cross linking via chondroitin 4 sulfate glycosaminoglycan | GO:0019800 | 8 | 0.032 | |
| regulation of ceramide biosynthetic process | GO:2000303 | 1 | 0.031 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.031 | |
| peptide cross linking | GO:0018149 | 10 | 0.031 | |
| intussusceptive angiogenesis | GO:0002041 | 2 | 0.030 | |
| response to monosaccharide | GO:0034284 | 67 | 0.030 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.029 | |
| positive regulation of bone resorption | GO:0045780 | 13 | 0.029 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.029 | |
| sequestering of bmp in extracellular matrix | GO:0035582 | 3 | 0.028 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.028 | |
| negative regulation of macrophage chemotaxis | GO:0010760 | 1 | 0.028 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.027 | |
| muscle cell development | GO:0055001 | 133 | 0.027 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.027 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.027 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.027 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.027 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.027 | |
| synaptic transmission cholinergic | GO:0007271 | 7 | 0.027 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.026 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.026 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.026 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.026 | |
| antimicrobial peptide secretion | GO:0002776 | 1 | 0.025 | |
| cellular response to mechanical stimulus | GO:0071260 | 7 | 0.025 | |
| regionalization | GO:0003002 | 337 | 0.025 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.025 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.025 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.024 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.024 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.023 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.023 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.023 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.023 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.022 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.022 | |
| cardiac chamber development | GO:0003205 | 108 | 0.022 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.022 | |
| synaptic transmission | GO:0007268 | 329 | 0.022 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.022 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.022 | |
| notochord cell differentiation | GO:0060034 | 1 | 0.021 | |
| protein maturation | GO:0051604 | 176 | 0.021 | |
| negative regulation of growth | GO:0045926 | 99 | 0.021 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.021 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.021 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.021 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.021 | |
| oxidation reduction process | GO:0055114 | 342 | 0.021 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.021 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.020 | |
| endothelium development | GO:0003158 | 45 | 0.020 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.020 | |
| regulation of system process | GO:0044057 | 200 | 0.020 | |
| telencephalon development | GO:0021537 | 186 | 0.020 | |
| negative regulation of biomineral tissue development | GO:0070168 | 11 | 0.019 | |
| axonogenesis | GO:0007409 | 274 | 0.019 | |
| protein processing | GO:0016485 | 163 | 0.019 | |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.019 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.019 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.019 | |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.019 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.018 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.018 | |
| biomineral tissue development | GO:0031214 | 64 | 0.018 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.018 | |
| hormone secretion | GO:0046879 | 128 | 0.018 | |
| regulation of bone resorption | GO:0045124 | 24 | 0.017 | |
| vegf activated neuropilin signaling pathway involved in axon guidance | GO:1902378 | 1 | 0.017 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.017 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.017 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.017 | |
| chondroitin sulfate metabolic process | GO:0030204 | 17 | 0.017 | |
| response to monoamine | GO:0071867 | 4 | 0.017 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.017 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.017 | |
| innate immune response | GO:0045087 | 157 | 0.017 | |
| regulation of macrophage migration inhibitory factor signaling pathway | GO:2000446 | 1 | 0.016 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.016 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.016 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.016 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.016 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.016 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.016 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.016 | |
| chondroitin sulfate proteoglycan metabolic process | GO:0050654 | 20 | 0.016 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.015 | |
| regulation of macrophage chemotaxis | GO:0010758 | 8 | 0.015 | |
| ear morphogenesis | GO:0042471 | 118 | 0.015 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.015 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.015 | |
| defense response to other organism | GO:0098542 | 197 | 0.015 | |
| regulation of synaptic vesicle priming | GO:0010807 | 4 | 0.015 | |
| chemotaxis | GO:0006935 | 247 | 0.015 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.015 | |
| synapse organization | GO:0050808 | 125 | 0.015 | |
| cell adhesion mediated by integrin | GO:0033627 | 18 | 0.014 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.014 | |
| cellular response to nitric oxide | GO:0071732 | 4 | 0.014 | |
| insulin processing | GO:0030070 | 2 | 0.014 | |
| male gamete generation | GO:0048232 | 285 | 0.014 | |
| regulation of transmission of nerve impulse | GO:0051969 | 1 | 0.014 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| oviduct development | GO:0060066 | 3 | 0.014 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.014 | |
| cell recognition | GO:0008037 | 83 | 0.013 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.013 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.013 | |
| negative regulation of endodermal cell differentiation | GO:1903225 | 1 | 0.013 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.013 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.013 | |
| positive regulation of growth | GO:0045927 | 104 | 0.012 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.012 | |
| endothelial cell migration | GO:0043542 | 44 | 0.012 | |
| odontogenesis | GO:0042476 | 78 | 0.012 | |
| lung alveolus development | GO:0048286 | 45 | 0.012 | |
| regulation of axon extension | GO:0030516 | 43 | 0.012 | |
| regulation of gastrulation | GO:0010470 | 16 | 0.012 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 1 | 0.012 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.012 | |
| response to radiation | GO:0009314 | 165 | 0.012 | |
| sperm egg recognition | GO:0035036 | 37 | 0.012 | |
| endochondral bone growth | GO:0003416 | 19 | 0.012 | |
| tissue remodeling | GO:0048771 | 102 | 0.012 | |
| gastrulation | GO:0007369 | 116 | 0.012 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.012 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.012 | |
| metanephric glomerular basement membrane development | GO:0072274 | 1 | 0.012 | |
| regulation of secretion | GO:0051046 | 274 | 0.012 | |
| salivary gland development | GO:0007431 | 37 | 0.011 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.011 | |
| bone trabecula morphogenesis | GO:0061430 | 12 | 0.011 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.011 | |
| developmental maturation | GO:0021700 | 193 | 0.011 | |
| cardiac cell development | GO:0055006 | 41 | 0.011 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.011 | |
| notch signaling pathway | GO:0007219 | 71 | 0.011 | |
| protein catabolic process | GO:0030163 | 221 | 0.011 | |
| response to steroid hormone | GO:0048545 | 56 | 0.011 | |
| macrophage colony stimulating factor signaling pathway | GO:0038145 | 2 | 0.011 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.011 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.011 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.011 | |
| cell cell adhesion | GO:0098609 | 41 | 0.011 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.011 | |
| protein autoprocessing | GO:0016540 | 2 | 0.011 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.011 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.011 | |
| medulla oblongata development | GO:0021550 | 3 | 0.011 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.011 | |
| wound healing spreading of cells | GO:0044319 | 8 | 0.011 | |
| renal system vasculature development | GO:0061437 | 15 | 0.011 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| antibacterial peptide biosynthetic process | GO:0002780 | 2 | 0.011 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.011 | |
| neuron death | GO:0070997 | 154 | 0.010 | |
| regulation of neuron death | GO:1901214 | 134 | 0.010 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.010 | |
| regulation of cell size | GO:0008361 | 72 | 0.010 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.010 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.010 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.010 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.010 | |
| macrophage migration inhibitory factor signaling pathway | GO:0035691 | 2 | 0.010 | |
| response to erythropoietin | GO:0036017 | 1 | 0.010 | |
| endocytosis | GO:0006897 | 168 | 0.010 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.010 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.010 | Human |